Widely international warfarin pharmacogenetics consortium warfarin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Diseases11

Hemorrhage Thromboembolism Atrial Fibrillation Drug-Related Side Effects and Adverse Reactions Stroke Intracranial Hemorrhages Genetic Predisposition to Disease Sleep Arousal Disorders Stevens-Johnson Syndrome Embolism Neoplasms

Chemicals and Drugs27

Warfarin Vitamin K Epoxide Reductases Anticoagulants Mixed Function Oxygenases Aryl Hydrocarbon Hydroxylases Cytochrome P-450 CYP2D6 Biomarkers, Pharmacological beta-Alanine Vitamin K Pharmaceutical Preparations Rodenticides Cytochrome P-450 Enzyme System Acenocoumarol Dihydrouracil Dehydrogenase (NADP)Methyltransferases Aspirin Vitamin K 1 Platelet Aggregation Inhibitors Cytochrome P-450 CYP3A 4-Hydroxycoumarins Benzimidazoles Azathioprine 6-Mercaptopurine Glucuronosyltransferase Organic Anion Transporters Codeine Antipsychotic Agents

Analytical, Diagnostic and Therapeutic Techniques and Equipment15

Individualized Medicine Prothrombin Time Drug Dosage Calculations Genetic Testing Drug Therapy Treatment Outcome Drug Monitoring Risk Factors Genome-Wide Association Study Clinical Trials as Topic International Normalized Ratio Drug Design Cohort Studies Risk Assessment Administration, Oral

Psychiatry and Psychology1

Sleep Arousal Disorders

Phenomena and Processes19

Polymorphism, Genetic Genotype Prothrombin Time Microbial Consortia Polymorphism, Single Nucleotide Drug Interactions Genetic Variation Metabolic Detoxication, Drug Dose-Response Relationship, Drug Phenotype Pharmacokinetics Alleles Gene Frequency Blood Coagulation Genetic Predisposition to Disease Genome, Human Biotransformation Haplotypes Drug Resistance

Disciplines and Occupations3

Pharmacogenetics Individualized Medicine Drug Design

Anthropology, Education, Sociology and Social Phenomena3

International Cooperation Pharmacy Residencies Internationality

Health Care9

Microbial Consortia International Agencies Genetic Testing Treatment Outcome Risk Factors Genome-Wide Association Study Clinical Trials as Topic Cohort Studies Risk Assessment

Geographicals1

Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Health Care Geographicals

Warfarin Pharmacogenetics Vitamin K Epoxide Reductases Anticoagulants Mixed Function Oxygenases Aryl Hydrocarbon Hydroxylases Individualized Medicine International Cooperation Cytochrome P-450 CYP2D6 Polymorphism, Genetic Genotype Prothrombin Time Hemorrhage Biomarkers, Pharmacological Thromboembolism Atrial Fibrillation Microbial Consortia Polymorphism, Single Nucleotide beta-Alanine Drug-Related Side Effects and Adverse Reactions Vitamin K Drug Dosage Calculations International Agencies Pharmaceutical Preparations Drug Interactions Genetic Variation Rodenticides Genetic Testing Drug Therapy Cytochrome P-450 Enzyme System Metabolic Detoxication, Drug Treatment Outcome Pharmacy Residencies Acenocoumarol Dose-Response Relationship, Drug Stroke Dihydrouracil Dehydrogenase (NADP)Internationality Drug Monitoring Methyltransferases Aspirin Vitamin K 1 Platelet Aggregation Inhibitors Cytochrome P-450 CYP3A Risk Factors Genome-Wide Association Study Clinical Trials as Topic International Normalized Ratio Phenotype Drug Design Pharmacokinetics United States Alleles Gene Frequency 4-Hydroxycoumarins Cohort Studies Blood Coagulation Intracranial Hemorrhages Genetic Predisposition to Disease Risk Assessment Benzimidazoles Azathioprine 6-Mercaptopurine Genome, Human Glucuronosyltransferase Sleep Arousal Disorders Administration, Oral Organic Anion Transporters Codeine Stevens-Johnson Syndrome Biotransformation Embolism Haplotypes Drug Resistance Neoplasms Antipsychotic Agents

No FAQ available that match "widely international warfarin pharmacogenetics consortium warfarin"